Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice

被引:0
作者
Victoria B Risbrough
Virginia L Masten
Sorana Caldwell
Martin P Paulus
Malcolm J Low
Mark A Geyer
机构
[1] University of California,Department of Psychiatry
[2] San Diego,Department of Behavioral Neuroscience
[3] Center for the Study of Weight Regulation,undefined
[4] and Vollum Institute,undefined
[5] Oregon Health & Science University,undefined
来源
Neuropsychopharmacology | 2006年 / 31卷
关键词
hyperactivity; dopamine; serotonin; mice; MDMA; receptor;
D O I
暂无
中图分类号
学科分类号
摘要
MDMA or ‘ecstasy’ (3,4-methylenedioxymethamphetamine) is a commonly used psychoactive drug that has unusual and distinctive behavioral effects in both humans and animals. In rodents, MDMA administration produces a unique locomotor activity pattern, with high activity characterized by smooth locomotor paths and perseverative thigmotaxis. Although considerable evidence supports a major role for serotonin release in MDMA-induced locomotor activity, dopamine (DA) receptor antagonists have recently been shown to attenuate these effects. Here, we tested the hypothesis that DA D1, D2, and D3 receptors contribute to MDMA-induced alterations in locomotor activity and motor patterns. DA D1, D2, or D3 receptor knockout (KO) and wild-type (WT) mice received vehicle or (+/−)-MDMA and were tested for 60 min in the behavioral pattern monitor (BPM). D1 KO mice exhibited significant increases in MDMA-induced hyperactivity in the late testing phase as well as an overall increase in straight path movements. In contrast, D2 KO mice exhibited reductions in MDMA-induced hyperactivity in the late testing phase, and exhibited significantly less sensitivity to MDMA-induced perseverative thigmotaxis. At baseline, D2 KO mice also exhibited reduced activity and more circumscribed movements compared to WT mice. Female D3 KO mice showed a slight reduction in MDMA-induced hyperactivity. These results confirm differential modulatory roles for D1 and D2 and perhaps D3 receptors in MDMA-induced hyperactivity. More specifically, D1 receptor activation appears to modify the type of activity (linear vs circumscribed), whereas D2 receptor activation appears to contribute to the repetitive circling behavior produced by MDMA.
引用
收藏
页码:2349 / 2358
页数:9
相关论文
共 261 条
[1]  
Accili D(1996)A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice Proc Natl Acad Sci USA 93 1945-1949
[2]  
Fishburn CS(1982)LSD-induced alterations of locomotor patterns and exploration in rats Psychopharmacology (Berlin) 77 179-185
[3]  
Drago J(1998)Striatal excitatory amino acid receptor subunit expression in the D1A-dopamine receptor-deficient mouse Dev Neurosci 20 237-241
[4]  
Steiner H(1995)Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors Nature 377 424-215
[5]  
Lachowicz JE(2003)Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors Brain Res 994 203-852
[6]  
Park BH(2001)3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin–dopamine interactions J Pharmacol Exp Ther 297 846-52
[7]  
Adams LM(2002)Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors Neuropsychopharmacology 26 40-655
[8]  
Geyer MA(1998)Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in serotonin transporter-deficient mice Mol Pharmacol 53 649-336
[9]  
Ariano MA(2004)Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA Psychopharmacology (Berlin) 173 326-301
[10]  
Drago J(1991)Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists Psychopharmacology (Berlin) 104 293-127